Mallinckrodt donates 250,000 Deterra drug deactivation pouches to ACT Missouri

Mallinckrodt Pharmaceuticals, a leading global specialty biopharmaceutical company, has purchased and donated 250,000 Deterra drug deactivation systems to ACT Missouri to provide patients and caregivers a secure, convenient, and environmentally safe way to dispose of unused medications.

The pouches deactivate prescription drugs and render chemical compounds safe for landfills. They will be distributed through the Missouri Substance Abuse Prevention Network. ACT Missouri facilitates this group of drug-abuse prevention leaders representing 160 community coalitions across the state.

“With Mallinckrodt’s support, we can further our mission to serve as the statewide prevention catalyst, empowering individuals and fostering partnerships to promote safe, healthy, and drug-free communities,” said Chuck Daugherty, Executive Director of ACT Missouri. “This partnership will help ensure the safe use and proper disposal of prescription medications for Missouri families.”